Instructions for Lincas BCC (plant-derived remedy) syrup 120 ml
English product name
Linkus BSS
Plant-based agent
Release form
Sirop
Description Lincas:
Brown syrup with a characteristic smell; a slight draught is allowed which disappears during lifting.
10ml
adhatoda leaves vascular extract 600 mg
dry licorice root extract 75 mg
dry extract of long peppers fruit and roots 100 mg
dry violet flower extract fragrant 25 mg
dry extract of issop leaves medicinal 50 mg
dry root and rhizome extract alpinia galanga 50 mg
dry fruit extract of cordia broadleaf 100 mg
dry extract of althea officinalis flowers 100 mg
dry extract of zizifusa fruit present 100 mg
dry extract of leaves and flowers onosma pritsvetnoy 100 mg
Auxiliary substances:
sodium saccharin 15 mg,
citric acid 20 mg, glycerol 1 g, propylene glycol 1.252 g, sorbitol solution 70% 4 g, methylparahydroxybenzoate 10.928 mg, propyl parahydroxybenzoate 2.168 mg, peppermint oil 2.75 mcl, clove oil 1.25 mcl, water purified up to 10 ml.
90 ml brown glass bottles (1) - cardboard packs.
120 ml brown glass bottles (1) - cardboard packs.
150 ml brown glass bottles (1) - cardboard packs.
ATC codes
R05CA10 Combination drugs
Clinical-pharmacological groups / Group affiliation
Phytopreparation with expectorant action
Active substance
- dry licorice root extract
- dry extract of long peppers fruit and roots
- dry violet flower extract fragrant
- dry extract of issop leaves medicinal
- dry root extract and roots alpinium galanga
- dry fruit extract of cordia broadleaf
- dry extract of althea officinalis flowers
- dry extract of zizifusa fruit present
Pharmacotherapy group
Plant-based agent
Special Instructions Lincas
It is not recommended to take anti-cough medicines at the same time, as well as medicines that reduce the formation of sputum.
Use in children
It is contraindicated in children under 6 months of age.
- Nosology (ICD codes)
- J04
- Acute laryngitis and tracheitis
- J06.9
- Acute upper respiratory tract infection unspecified
- J10
- Influenza caused by an identified seasonal influenza virus
- J15
- Bacterial pneumonia not classified elsewhere
- J20
- Acute bronchitis
- J37
- Chronic laryngitis and laryngotracheitis
- J42
- Chronic bronchitis unspecified
- R05
- Cough
Pharmacological effect Lincas:
A combined plant preparation. Reduces the intensity and increases the productivity of the cough, has expectorant, mucolytic and anti-inflammatory effects.
The vascular adkhatoda has anti-cough, broncholytic, expectorant and spasmolytic effects.
The smooth licorice root contains glycyrrysin and foam-forming agents, i.e. saponins, which promote the secretory function of the epithelium of the respiratory tract, modify the surface-active properties of the pulmonary surfactant, stimulate the movement of the epithelium cilia, stimulate the sputum and facilitate its withdrawal. It has a depressing effect on the exudative and proliferative phase of inflammation. It has anti-allergic properties.
Peppers long has antibacterial, anti-allergic properties. It has anti-cough and general tonic effects.
Fialca Fragrance has anti-inflammatory, analgesic, sedative, antimicrobial and spasmolytic effects.
Issop vulgaris contains diosmin, which has an antiseptic, anti-inflammatory, analgesic and anti-cough effect.
Kalgan has a great bactericidal effect, has anti-inflammatory and expectorant properties.
Alteus vulgaris has an expectorant and anti-inflammatory effect.
Zizyfus is a mild, mild, mild, and highly sedative.
Testimony:
Symptomatic therapy of infectious and inflammatory diseases of the respiratory tract, accompanied by cough with hard-to-separate sputum (against the background of ARVI, influenza, tracheitis, bronchitis, tracheobronchitis, pneumonia, smoker's bronchitis and other inflammatory diseases of the respiratory tract).
Dosage, Course and Dosage:
Inwards. The dose, frequency of use and duration of the course of treatment depend on the age of the patient and the clinical picture of the disease.
